Emerson W Chan is a notable inventor based in Libertyville, IL (US). He has made significant contributions to the field of immunoassays, particularly in the detection of viral antibodies. With a total of 4 patents to his name, Chan's work has advanced the methodologies used in medical diagnostics.

Latest Patents

One of Chan's latest patents is titled "Methods for the detection of HTLV-II antibodies employing novel HTLV-II NRA envelope peptides." This invention relates to a novel human T-cell lymphotropic virus type II (HTLV-II) isolate designated NRA, which was originally isolated from a patient with atypical hairy cell leukemia. The invention focuses on the gp46 and p21 envelope proteins encoded by the env gene, providing methods and kits for the detection of HTLV-II antibodies. Another significant patent is "Process for preparing an improved western blot immunoassay." This patent encompasses an improved immunoassay method that allows for the simultaneous transfer of multiple antigens onto a single solid support, enhancing the sensitivity of assays for detecting antibodies to HIV-1 or HIV-2 viruses in infected patients.

Career Highlights

Emerson W Chan is currently associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His work at Abbott has allowed him to focus on innovative solutions in the field of diagnostics, contributing to the development of advanced immunoassay techniques.

Collaborations

Throughout his career, Chan has collaborated with notable colleagues, including Werner Schulze and William G Robey. These collaborations have further enriched his research and development efforts in the field of immunology.

Conclusion

Emerson W Chan's contributions to immunoassay technologies have made a significant impact on medical diagnostics. His innovative patents and work at Abbott Laboratories Corporation highlight his dedication to advancing healthcare solutions.